-
1
المؤلفون: Jbl Hoekstra, J. W. Vermeijden, E. M. Kuck, E. Holleman
المصدر: The Lancet. 351:833-834
مصطلحات موضوعية: Cartridge, Chromatography, Chemistry, Insulin, medicine.medical_treatment, medicine, General Medicine
-
2
المؤلفون: Hjm Van Rijn, Jhh Thijssen, Jbl Hoekstra
المصدر: Annals of clinical biochemistry. 19(Pt 5)
مصطلحات موضوعية: 030213 general clinical medicine, Chromatography, C-Peptide, Chemistry, C-peptide, Clinical Biochemistry, Radioimmunoassay, Cross reactions, 030209 endocrinology & metabolism, General Medicine, Cross Reactions, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Evaluation Studies as Topic, Intermethod comparison, Humans, Peg precipitation, Reagent Kits, Diagnostic, Peptides, Proinsulin
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a46138cb817ae8d124ac06829a0448be
https://pubmed.ncbi.nlm.nih.gov/7137871 -
3دورية أكاديمية
المؤلفون: de Groot PF; Department of Internal and Vascular Medicine, Academic Medical Center, Meibergdreef 9, Room D3-316, 1105 AZ, Amsterdam, the Netherlands. p.f.degroot@amsterdamumc.nl., Nikolic T; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands., Imangaliyev S; Department of Internal and Vascular Medicine, Academic Medical Center, Meibergdreef 9, Room D3-316, 1105 AZ, Amsterdam, the Netherlands., Bekkering S; Department of Internal and Vascular Medicine, Academic Medical Center, Meibergdreef 9, Room D3-316, 1105 AZ, Amsterdam, the Netherlands.; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands., Duinkerken G; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands., Keij FM; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands., Herrema H; Department of Internal and Vascular Medicine, Academic Medical Center, Meibergdreef 9, Room D3-316, 1105 AZ, Amsterdam, the Netherlands., Winkelmeijer M; Department of Internal and Vascular Medicine, Academic Medical Center, Meibergdreef 9, Room D3-316, 1105 AZ, Amsterdam, the Netherlands., Kroon J; Department of Internal and Vascular Medicine, Academic Medical Center, Meibergdreef 9, Room D3-316, 1105 AZ, Amsterdam, the Netherlands., Levin E; Department of Internal and Vascular Medicine, Academic Medical Center, Meibergdreef 9, Room D3-316, 1105 AZ, Amsterdam, the Netherlands., Hutten B; Department of Epidemiology, Amsterdam University Medical Centers, Academic Medical Centre, Amsterdam, the Netherlands., Kemper EM; Clinical Pharmacy, Amsterdam University Medical Centers, Academic Medical Centre, Amsterdam, the Netherlands., Simsek S; Department of Internal Medicine, Alkmaar Medical Center (MCA), Alkmaar, the Netherlands., Levels JHM; Department of Internal and Vascular Medicine, Academic Medical Center, Meibergdreef 9, Room D3-316, 1105 AZ, Amsterdam, the Netherlands., van Hoorn FA; Department of Internal and Vascular Medicine, Academic Medical Center, Meibergdreef 9, Room D3-316, 1105 AZ, Amsterdam, the Netherlands., Bindraban R; Department of Internal and Vascular Medicine, Academic Medical Center, Meibergdreef 9, Room D3-316, 1105 AZ, Amsterdam, the Netherlands., Berkvens A; Department of Internal and Vascular Medicine, Academic Medical Center, Meibergdreef 9, Room D3-316, 1105 AZ, Amsterdam, the Netherlands., Dallinga-Thie GM; Department of Internal and Vascular Medicine, Academic Medical Center, Meibergdreef 9, Room D3-316, 1105 AZ, Amsterdam, the Netherlands., Davids M; Department of Internal and Vascular Medicine, Academic Medical Center, Meibergdreef 9, Room D3-316, 1105 AZ, Amsterdam, the Netherlands., Holleman F; Department of Internal and Vascular Medicine, Academic Medical Center, Meibergdreef 9, Room D3-316, 1105 AZ, Amsterdam, the Netherlands., Hoekstra JBL; Department of Internal and Vascular Medicine, Academic Medical Center, Meibergdreef 9, Room D3-316, 1105 AZ, Amsterdam, the Netherlands., Stroes ESG; Department of Internal and Vascular Medicine, Academic Medical Center, Meibergdreef 9, Room D3-316, 1105 AZ, Amsterdam, the Netherlands., Netea M; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.; Department for Genomics & Immunoregulation, Life and Medical Sciences Institute (LIMES), University of Bonn, Bonn, Germany., van Raalte DH; Department of Internal and Vascular Medicine, Academic Medical Center, Meibergdreef 9, Room D3-316, 1105 AZ, Amsterdam, the Netherlands.; Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, VU University Medical Centre, Amsterdam, the Netherlands., Roep BO; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands.; Department of Diabetes Immunology, Diabetes & Metabolism Research Institute at the Beckman Research Institute, City of Hope, Duarte, CA, USA., Nieuwdorp M; Department of Internal and Vascular Medicine, Academic Medical Center, Meibergdreef 9, Room D3-316, 1105 AZ, Amsterdam, the Netherlands.; Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, VU University Medical Centre, Amsterdam, the Netherlands.
المصدر: Diabetologia [Diabetologia] 2020 Mar; Vol. 63 (3), pp. 597-610. Date of Electronic Publication: 2020 Jan 08.
نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE
مواضيع طبية MeSH: Autoimmunity/*drug effects , Butyric Acid/*administration & dosage , Diabetes Mellitus, Type 1/*drug therapy , Immunity, Innate/*drug effects , Islets of Langerhans/*immunology, Adaptive Immunity/drug effects ; Administration, Oral ; Adult ; Butyric Acid/adverse effects ; Diabetes Mellitus, Type 1/immunology ; Diabetes Mellitus, Type 1/pathology ; Disease Progression ; Female ; Humans ; Islets of Langerhans/drug effects ; Male ; Middle Aged ; Netherlands ; Time Factors ; Young Adult
-
4دورية أكاديمية
المؤلفون: de Groot P; Department of Internal and Vascular Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Scheithauer T; Department of Internal and Vascular Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Bakker GJ; Department of Internal and Vascular Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Prodan A; Department of Internal and Vascular Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Levin E; Department of Internal and Vascular Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Khan MT; Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, Goteborgs Universitet, Gothenburg, Sweden., Herrema H; Department of Internal and Vascular Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Ackermans M; Department of Internal and Vascular Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Serlie MJM; Department of Internal and Vascular Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands., de Brauw M; Department of Surgery, Spaarne Gasthuis, Haarlem, The Netherlands., Levels JHM; Department of Internal and Vascular Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Sales A; Department of Internal and Vascular Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Gerdes VE; Department of Internal and Vascular Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Ståhlman M; Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, Goteborgs Universitet, Gothenburg, Sweden., Schimmel AWM; Department of Internal and Vascular Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Dallinga-Thie G; Department of Internal and Vascular Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Bergman JJ; Department of Gastroenterology, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Holleman F; Department of Internal and Vascular Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Hoekstra JBL; Department of Internal and Vascular Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Groen A; Department of Internal and Vascular Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Bäckhed F; Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, Goteborgs Universitet, Gothenburg, Sweden., Nieuwdorp M; Department of Internal and Vascular Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
المصدر: Gut [Gut] 2020 Mar; Vol. 69 (3), pp. 502-512. Date of Electronic Publication: 2019 May 30.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE
مواضيع طبية MeSH: Fecal Microbiota Transplantation* , Gastric Bypass* , Insulin Resistance*, Glucose/*metabolism , Metabolic Syndrome/*metabolism, Adult ; Aged ; Bile Acids and Salts/analysis ; Chemokine CCL2/blood ; Chemokine CCL2/genetics ; Energy Metabolism ; Fatty Acids, Volatile/analysis ; Feces/chemistry ; Gastrointestinal Microbiome ; Gastrointestinal Transit ; Gene Expression ; Humans ; Lipolysis ; Male ; Metabolic Syndrome/physiopathology ; Metabolic Syndrome/therapy ; Metabolomics ; Middle Aged ; Subcutaneous Fat/metabolism ; Tissue Donors ; Young Adult
-
5دورية أكاديمية
المؤلفون: Gerards MC; Department of Internal Medicine, MC Slotervaart, Amsterdam, The Netherlands., Venema GE; Department of Pulmonology, Isala, Zwolle, The Netherlands., Patberg KW; Department of Pulmonology, Isala, Zwolle, The Netherlands., Kross M; Department of Pulmonology, MC Slotervaart, Amsterdam, The Netherlands., Potter van Loon BJ; Department of Internal Medicine, OLVG West, Amsterdam, The Netherlands., Hageman IMG; Department of Internal Medicine, OLVG West, Amsterdam, The Netherlands., Snijders D; Department of Pulmonology, Spaarne Gasthuis, Hoofddorp, The Netherlands., Brandjes DPM; Department of Internal Medicine, MC Slotervaart, Amsterdam, The Netherlands., Hoekstra JBL; Academic Medical Centre, Department of Internal Medicine, Amsterdam, The Netherlands., Vriesendorp TM; Department of Internal Medicine, Isala, Zwolle, The Netherlands., Gerdes VEA; Department of Internal Medicine, MC Slotervaart, Amsterdam, The Netherlands.
المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2018 May; Vol. 20 (5), pp. 1306-1310. Date of Electronic Publication: 2018 Feb 06.
نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE
مواضيع طبية MeSH: Benzhydryl Compounds/*therapeutic use , Glucocorticoids/*adverse effects , Glucosides/*therapeutic use , Hyperglycemia/*chemically induced , Hyperglycemia/*drug therapy , Prednisone/*adverse effects , Pulmonary Disease, Chronic Obstructive/*therapy , Sodium-Glucose Transporter 2 Inhibitors/*therapeutic use, Aged ; Benzhydryl Compounds/adverse effects ; Combined Modality Therapy/adverse effects ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/drug therapy ; Diabetes Mellitus, Type 2/metabolism ; Double-Blind Method ; Drug Therapy, Combination/adverse effects ; Female ; Glucocorticoids/therapeutic use ; Glucose/metabolism ; Glucosides/adverse effects ; Humans ; Hypoglycemia/chemically induced ; Hypoglycemia/prevention & control ; Hypoglycemic Agents/administration & dosage ; Hypoglycemic Agents/adverse effects ; Hypoglycemic Agents/therapeutic use ; Insulin/administration & dosage ; Insulin/adverse effects ; Insulin/therapeutic use ; Insulin Resistance ; Length of Stay ; Male ; Middle Aged ; Monitoring, Ambulatory ; Prednisone/therapeutic use ; Pulmonary Disease, Chronic Obstructive/complications ; Pulmonary Disease, Chronic Obstructive/metabolism ; Pulmonary Disease, Chronic Obstructive/physiopathology ; Severity of Illness Index ; Sodium-Glucose Transporter 2 Inhibitors/adverse effects ; Subcutaneous Tissue/metabolism
-
6دورية أكاديمية
المؤلفون: Udayappan SD; Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands., Kovatcheva-Datchary P; Wallenberg Laboratory, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden., Bakker GJ; Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands., Havik SR; Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands., Herrema H; Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands., Cani PD; Université catholique de Louvain, WELBIO (Walloon Excellence in Life sciences and BIOtechnology), Louvain Drug Research Institute, Brussels, Belgium., Bouter KE; Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands., Belzer C; Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands., Witjes JJ; Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands., Vrieze A; Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands., de Sonnaville ESV; Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands., Chaplin A; Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands., van Raalte DH; Diabetes Center, Department of Internal medicine, VU University Medical Center, Amsterdam, The Netherlands.; ICAR, VU University Medical Center, Amsterdam, The Netherlands., Aalvink S; Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands., Dallinga-Thie GM; Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands., Heilig HGHJ; Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands., Bergström G; Wallenberg Laboratory, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden., van der Meij S; Department of Surgery, Flevo Hospital, Almere, The Netherlands., van Wagensveld BA; Department of Surgery, Sint Lucas Andreas Hospital, Amsterdam, The Netherlands., Hoekstra JBL; Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands., Holleman F; Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands., Stroes ESG; Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands., Groen AK; Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.; Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Bäckhed F; Wallenberg Laboratory, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.; Novo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Receptology and Enteroendocrinology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark., de Vos WM; Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands.; RPU Immunobiology, University of Helsinki, Helsinki, Finland., Nieuwdorp M; Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.; Wallenberg Laboratory, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands.; Diabetes Center, Department of Internal medicine, VU University Medical Center, Amsterdam, The Netherlands.; ICAR, VU University Medical Center, Amsterdam, The Netherlands.
المصدر: PloS one [PLoS One] 2017 Nov 22; Vol. 12 (11), pp. e0181693. Date of Electronic Publication: 2017 Nov 22 (Print Publication: 2017).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
مواضيع طبية MeSH: Glucose Intolerance/*complications , Glucose Intolerance/*microbiology , Gram-Negative Bacterial Infections/*microbiology , Intestines/*microbiology , Obesity/*complications , Obesity/*microbiology , Ralstonia pickettii/*physiology, Aged ; Animals ; DNA, Bacterial/analysis ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/microbiology ; Diet, High-Fat ; Feces/microbiology ; Female ; Gram-Negative Bacterial Infections/pathology ; Humans ; Inflammation/complications ; Inflammation/pathology ; Intestines/pathology ; Intra-Abdominal Fat/microbiology ; Intra-Abdominal Fat/pathology ; Male ; Mice, Inbred C57BL
-
7دورية أكاديمية
المؤلفون: Gerards MC; MC Slotervaart, Amsterdam, The Netherlands. Electronic address: m.c.gerards@amc.uva.nl., van der Velden DL; Antoni van Leeuwenhoek Hospital/Dutch Cancer Institute, Amsterdam, The Netherlands., Baars JW; Antoni van Leeuwenhoek Hospital/Dutch Cancer Institute, Amsterdam, The Netherlands., Brandjes DPM; MC Slotervaart, Amsterdam, The Netherlands., Hoekstra JBL; Academic Medical Center, Amsterdam, The Netherlands., Vriesendorp TM; Isala, Zwolle, The Netherlands., Gerdes VEA; MC Slotervaart, Amsterdam, The Netherlands.
المصدر: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2017 May; Vol. 113, pp. 235-241. Date of Electronic Publication: 2017 Mar 10.
نوع المنشور: Journal Article; Review; Systematic Review
بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Hyperglycemia/*complications , Neoplasms/*drug therapy, Animals ; Blood Glucose/analysis ; Cell Line, Tumor ; Humans ; Male ; Neoplasms/metabolism ; Receptors, Estrogen/analysis
-
8دورية أكاديمية
المؤلفون: Schopman JE; Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands., Hoekstra JBL; Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands., Frier BM; Department of Diabetes, Royal Infirmary of Edinburgh, Edinburgh, UK., Ackermans MT; Department of Clinical Chemistry, Laboratory of Endocrinology and Radiochemistry, Academic Medical Center, Amsterdam, The Netherlands., de Sonnaville JJJ; Department of Internal Medicine, Tergooi, Hilversum, The Netherlands., Stades AM; Department of Internal Medicine, University Medical Center, Utrecht, The Netherlands., Zwertbroek R; Department of Internal Medicine, Westfriesgasthuis, Hoorn, The Netherlands., Hartmann B; Department of Biomedical Sciences, NNF Centre for Basic Metabolic Research, Panum Institute, University of Copenhagen, Copenhagen, Denmark., Holst JJ; Department of Biomedical Sciences, NNF Centre for Basic Metabolic Research, Panum Institute, University of Copenhagen, Copenhagen, Denmark., Knop FK; Department of Biomedical Sciences, NNF Centre for Basic Metabolic Research, Panum Institute, University of Copenhagen, Copenhagen, Denmark.; Department of Internal Medicine, Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark., Holleman F; Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands.
المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2015 Jun; Vol. 17 (6), pp. 546-553. Date of Electronic Publication: 2015 Mar 24.
نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE
مواضيع طبية MeSH: Diabetes Mellitus, Type 1/*drug therapy , Dipeptidyl-Peptidase IV Inhibitors/*pharmacology , Glucagon/*drug effects , Hypoglycemia/*blood , Incretins/*metabolism , Sitagliptin Phosphate/*pharmacology, Adolescent ; Adult ; Cross-Over Studies ; Diabetes Mellitus, Type 1/blood ; Diabetes Mellitus, Type 1/complications ; Double-Blind Method ; Gastric Inhibitory Polypeptide/metabolism ; Glucagon-Like Peptide 1/metabolism ; Growth Hormone/drug effects ; Humans ; Hypoglycemia/etiology ; Male ; Middle Aged ; Young Adult